BioCentury
ARTICLE | Company News

Commonwealth Laboratories, Valeant Pharmaceuticals deal

September 7, 2015 7:00 AM UTC

Valeant will acquire Commonwealth’s U.S. and Canadian business for an undisclosed upfront payment. Commonwealth is also eligible for undisclosed sales milestones. The deal includes IBSchek, an ELISA-...